151 related articles for article (PubMed ID: 31155323)
21. Diagnosis, pathogenesis and outcome in leucocyte chemotactic factor 2 (ALECT2) amyloidosis.
Rezk T; Gilbertson JA; Rowczenio D; Bass P; Lachmann HJ; Wechalekar AD; Fontana M; Mahmood S; Sachchithanantham S; Whelan CJ; Wong J; Rendell N; Taylor GW; Hawkins PN; Gillmore JD
Nephrol Dial Transplant; 2018 Feb; 33(2):241-247. PubMed ID: 29401357
[TBL] [Abstract][Full Text] [Related]
22. Renal LECT2 amyloidosis: a newly described disorder gaining greater recognition.
Kowalski A; Cabrera J; Nasr S; Lerma E
Clin Nephrol; 2015 Oct; 84(4):236-40. PubMed ID: 26308079
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsies.
Larsen CP; Walker PD; Weiss DT; Solomon A
Kidney Int; 2010 May; 77(9):816-9. PubMed ID: 20182418
[TBL] [Abstract][Full Text] [Related]
24. Donor-Derived ALECT2 Amyloidosis and Recurrent Fibrillary Glomerulonephritis in a Transplant Allograft.
Nasr SH; Chavez O; Dasari S; Theis JD; Vrana JA; Fatima H; Fu L; Baliga RS; McPhail ED
Kidney Med; 2021; 3(3):433-437. PubMed ID: 34136788
[TBL] [Abstract][Full Text] [Related]
25. Nephrotic syndrome in the setting of LECT2 amyloidosis: Take a look at the podocyte.
Valdés-Lagunes DA; Méndez-Pérez RA; de la Cruz MA; Uribe-Uribe NO; Mejía-Vilet JM
Clin Nephrol; 2020 Nov; 94(5):266-270. PubMed ID: 32870148
[TBL] [Abstract][Full Text] [Related]
26. Leukocyte Cell-Derived Chemotaxin 2-Associated Renal Amyloidosis: A Case Report.
Kaur G; Bijin B; Saleem K; Sarsah B; Thajudeen B
Case Rep Nephrol Dial; 2017; 7(2):121-129. PubMed ID: 29464179
[TBL] [Abstract][Full Text] [Related]
27. Renal amyloidogenic leukocyte chemotactic factor 2 combined with IgA nephropathy: A case report.
Xu H; Jia Y; Wang X; Wang H; Yu J; Hao W
Medicine (Baltimore); 2022 Jul; 101(29):e29638. PubMed ID: 35866785
[TBL] [Abstract][Full Text] [Related]
28. Karyomegalic interstitial nephritis with a novel FAN1 gene mutation and concurrent ALECT2 amyloidosis.
Law S; Gillmore J; Gilbertson JA; Bass P; Salama AD
BMC Nephrol; 2020 Feb; 21(1):74. PubMed ID: 32111193
[TBL] [Abstract][Full Text] [Related]
29. Pathology and diagnosis of renal non-AL amyloidosis.
Sethi S; Theis JD
J Nephrol; 2018 Jun; 31(3):343-350. PubMed ID: 28828707
[TBL] [Abstract][Full Text] [Related]
30. [Incidental finding of leukocyte cell-derived chemotaxin 2 - Associated amyloidosis in a liver].
Gibier JB; Gilbertson JA; Perbet R; Leriche W; Truant S; Leteurtre E; Gillmore JD; Gnemmi V
Ann Pathol; 2020 Nov; 40(6):472-477. PubMed ID: 32446730
[TBL] [Abstract][Full Text] [Related]
31. LECT-2 amyloidosis: what do we know?
Mann BK; Bhandohal JS; Cobos E; Chitturi C; Eppanapally S
J Investig Med; 2022 Feb; 70(2):348-353. PubMed ID: 34848562
[TBL] [Abstract][Full Text] [Related]
32. Secondary bladder amyloidosis with familial Mediterranean fever in a living donor kidney transplant recipient: a case report.
Imamura S; Narita S; Nishikomori R; Tsuruta H; Numakura K; Maeno A; Saito M; Inoue T; Tsuchiya N; Nanjo H; Heike T; Satoh S; Habuchi T
BMC Res Notes; 2016 Oct; 9(1):473. PubMed ID: 27760547
[TBL] [Abstract][Full Text] [Related]
33. Loss of bound zinc facilitates amyloid fibril formation of leukocyte-cell-derived chemotaxin 2 (LECT2).
Ha JH; Tu HC; Wilkens S; Loh SN
J Biol Chem; 2021; 296():100446. PubMed ID: 33617884
[TBL] [Abstract][Full Text] [Related]
34. Mimicking Kidney Flow Shear Efficiently Induces Aggregation of LECT2, a Protein Involved in Renal Amyloidosis.
Ha JH; Xu Y; Sekhon H; Wilkens S; Ren D; Loh SN
bioRxiv; 2023 Jul; ():. PubMed ID: 37503176
[TBL] [Abstract][Full Text] [Related]
35. Two novel APOA1 gene mutations in a Japanese renal transplant recipient with recurrent apolipoprotein A-I related amyloidosis.
Horike K; Takeda A; Tsujita M; Goto N; Watarai Y; Uchida K; Katayama A; Nishihira M; Shimizu A; Nozu K; Morozumi K
Nephrology (Carlton); 2018 Jul; 23 Suppl 2():17-21. PubMed ID: 29968409
[TBL] [Abstract][Full Text] [Related]
36. Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis.
Said SM; Sethi S; Valeri AM; Chang A; Nast CC; Krahl L; Molloy P; Barry M; Fidler ME; Cornell LD; Leung N; Vrana JA; Theis JD; Dogan A; Nasr SH
Kidney Int; 2014 Aug; 86(2):370-7. PubMed ID: 24451324
[TBL] [Abstract][Full Text] [Related]
37. LECT2-associated renal amyloidosis (ALECT2): A case report.
Ortega Junco E; Sánchez González C; Serrano Pardo R; Lamana Dominguez A; Santos Sánchez B; Sanz Sainz M; Saharaui Catala Y; Sánchez Tomero JA
Nefrologia (Engl Ed); 2018; 38(5):558-560. PubMed ID: 29254900
[No Abstract] [Full Text] [Related]
38. A case of renal and splenic LECT 2 amyloidosis: A recently recognized cause of renal and systemic amyloidosis.
Shye M; Sisk A; Schulze C; Barsoum M; Mikhail M; Arman F; Rastogi A; Hanna RM
Saudi J Kidney Dis Transpl; 2020; 31(2):508-514. PubMed ID: 32394925
[TBL] [Abstract][Full Text] [Related]
39. Alect2 amyloidosis: primum non nocere (first, do no harm).
Picken MM
Kidney Int; 2014 Aug; 86(2):229-32. PubMed ID: 25079018
[TBL] [Abstract][Full Text] [Related]
40. Rare, Yet Emerging Cause of Graft Dysfunction-ALECT 2 Amyloidosis.
Singh K; Sethi J; Duggal R; Joshi K; Bains AS
Indian J Nephrol; 2020; 30(3):204-206. PubMed ID: 33013073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
